Prudential Financial, Inc. 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-15 10:35 am Sale | 2024-11-14 | 13G | Marinus Pharmaceuticals, Inc. MRNS | PRUDENTIAL FINANCIAL INC PRU | 385,250 0.700% | -2,924,741 (-88.36%) | Filing |
| 2024-02-14 10:35 am Purchase | 2024-02-12 | 13G | Marinus Pharmaceuticals, Inc. MRNS | PRUDENTIAL FINANCIAL INC PRU | 3,309,991 6.070% | 3,309,991 (New Position) | Filing |